查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1919307

奈米孔單分子定序儀市場：按產品類型、經營模式、應用和最終用戶分類－2026-2032年全球預測

Nanopore Single Molecule Sequencer Market by Product Type, Business Model, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年奈米孔單分子定序儀市值為 8.1294 億美元，預計到 2026 年將成長至 8.7992 億美元，到 2032 年預計將達到 12.4867 億美元，複合年成長率為 6.32%。

關鍵市場統計數據
基準年 2025 8.1294億美元
預計年份：2026年 8.7992億美元
預測年份 2032 12.4867億美元
複合年成長率 (%) 6.32%

本文簡要介紹了單分子奈米孔定序如何改變實驗室工作流程，實現長讀長分析，並迅速擴大轉化研究的機會。

本文將奈米孔單分子定序定位為一項催化技術，它將重塑科學研究和臨床工作流程中的分子分析方式。奈米孔技術無需擴增即可對天然核酸進行即時長讀長定定序，在結構變異檢測、表觀遺傳分析、直接RNA定序和快速病原體鑑定方面具有獨特的優勢。孔道化學、感測器電子學和演算法鹼基辨識方面的進步，共同提高了定序的準確性、通量和易用性，從而促進了該技術在專業基因組學實驗室之外的更廣泛應用。

奈米孔定序系統中推動快速演進和策略調整的關鍵技術、營運和商業性轉折點

奈米定序領域正經歷技術、操作和商業性等多個層面的變革。在技​​術層面，孔道化學、馬達蛋白和訊號處理技術的進步縮小了奈米孔定序與其他定序方法之間的準確性差距，並解鎖了諸如直接分析甲基化和RNA修飾等獨特功能。這些進步與鹼基辨識和糾錯演算法的改進相輔相成，降低了資訊處理負擔，使長讀長定序資料更適用於下游分析。

美國近期關稅政策的變化對奈米孔定序價值定序的短期採購壓力和長期供應鏈韌性措施都產生了影響。

美國2025年實施的關稅調整的累積影響，為奈米孔定序價值定序帶來了複雜的挑戰，也促使各方採取相應的策略應對措施。進口零件和設備的關稅相關成本上漲，增加了實驗室營運商和服務供應商的採購成本，對採購週期和資本支出核准造成了短期壓力。為因應這些挑戰，有些製造商加快了供應鏈在地化和策略採購，以降低風險；而有些製造商則選擇暫時承擔部分成本，以維繫與關鍵客戶的關係。

將產品層級、應用領域、最終用戶需求和商業經營模式連結起來的可操作細分分析，有助於確定策略投資的優先順序。

細分市場分析揭示了技術重點領域、臨床應用和商業性指南，從而指導策略規劃和產品優先排序。根據產品類型，市場被分為三個部分：耗材、儀器和軟體。耗材進一步細分為流通池和試劑盒。儀器分為網格、微型和專業儀器。軟體分為分析軟體和雲端解決方案。這種產品層面的細分錶明，持續的耗材和分析軟體構成了商業模式的核心，而儀器的分級則滿足了不同的處理能力和部署需求。

區域採用模式和監管趨勢塑造了美洲、歐洲、中東和非洲以及亞太市場差異化的商業性擴張策略

區域趨勢揭示了不同的技術採納模式、監管路徑和商業化路徑，這些因素會影響策略性市場進入和擴張決策。在美洲，強大的學術網路、充足的創業投資資金和成熟的生物技術叢集正在加速技術採納，尤其是在轉化研究和臨床試驗開發領域。北美臨床實驗室和生物製藥公司往往是早期採用者，這得益於它們檢驗和規模化生產能力；而可現場部署的應用則受益於成熟的公共衛生和國防採購管道。

在奈米孔定序系統中，競爭與合作趨勢評估包括整合解決方案、檢驗的工作流程和以客戶為中心的服務。

奈米孔定序生態系的競爭動態呈現出成熟領導者、快速創新者和不斷壯大的專業夥伴三者並存的態勢。主要儀器供應商優先投資於硬體的迭代改進、耗材生態系統的開發以及分析技術的研發，以提升易用性和臨床應對力。同時，專業試劑生產商和新興企業則專注於開發最佳化的化學方法和試劑盒，以提高通量、準確性和樣本製備流程。軟體供應商和雲端分析供應商正在建立模組化、擴充性的平台，支援鹼基識別、變異檢測、甲基化檢測和整合式視覺化，從而加快終端用戶獲得分析結果的速度。

經營團隊在推動奈米孔定序市場應用、增強韌性和持續創造價值方面的具體策略重點

業界領導者應採取一系列切實可行、影響深遠的舉措，在把握新機會的同時管控營運風險。首先，應優先制定模組化產品藍圖，將設備等級與清晰的應用路徑和檢驗的工作流程相匹配，使客戶能夠根據自身用例選擇合適的平台功能。其次，應拓展耗材生態系統和訂閱軟體產品，以推動經常性收入成長並加深客戶參與，同時確保價格透明和供應承諾可預測。

採用透明的多方法研究途徑，結合一手訪談、技術文獻回顧和三角驗證分析，幫助您做出自信的策略決策。

本調查方法融合了定性和定量方法，旨在最大限度地減少偏差，確保透明度，並得出可靠且可重複的結論。主要研究包括對設備工程師、實驗室主任、採購人員、監管專家和高級研發主管進行結構化訪談，以獲取有關技術性能、檢驗挑戰和採購行為的第一手資料。此外，還對同行評審文獻、檢驗研究和會議論文進行了技術審查，以確保研究結果有科學檢驗。

策略概述重點介紹奈米孔定序技術的優勢、關鍵營運挑戰以及有效將其納入主流所需的生態系統利用策略。

總之，奈米孔單分子定序在更廣泛的基因組學領域佔據著一個獨特且不斷擴展的細分市場，其特點在於長讀長分析、直接修飾檢測和即時數據生成等方面的獨特能力。技術的成熟、多樣化的儀器產品組合以及不斷發展的軟體生態系統正在降低其在科研、臨床和現場應用領域的普及門檻。然而，成功的規模化應用需要生態系層面的協調配合。具體而言，它需要穩健的耗材供應鏈、檢驗的工作流程、符合監管要求的準備以及能夠為最終用戶帶來可預測價值的引人注目的商業模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的奈米孔單分子定序儀市場

  • 消耗品
    • 流動池
    • 成套工具
  • 裝置
    • 葛萊迪翁
    • 小小兵
    • 鯛
  • 軟體
    • 分析軟體
    • 雲端解決方案

9. 依經營模式分類的奈米孔單分子定序儀市場

  • 產品銷售
  • 服務協定

第10章 奈米孔單分子定序儀市場（依應用分類）

  • 臨床診斷
  • 表觀基因
  • 基因組學
  • 總體基因體學
  • 轉錄組學

第11章 依最終用戶分類的奈米孔單分子定序儀市場

  • 學術和政府機構
  • 生物製藥和製藥公司
  • 臨床檢查室
  • CRO（受託研究機構）

12. 奈米孔單分子定序儀市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 奈米孔單分子定序儀市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國奈米孔單分子定序儀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章美國奈米孔單分子定序儀市場

第16章：中國奈米孔單分子定序儀市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Direct Genomics Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Genapsys, Inc.
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • Microsynth AG
  • Nabsys, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Quantum Biosystems Inc.
  • SeqLL Inc.
  • Stratos Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation
Product Code: MRR-F14BA1B341A4

The Nanopore Single Molecule Sequencer Market was valued at USD 812.94 million in 2025 and is projected to grow to USD 879.92 million in 2026, with a CAGR of 6.32%, reaching USD 1,248.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 812.94 million
Estimated Year [2026] USD 879.92 million
Forecast Year [2032] USD 1,248.67 million
CAGR (%) 6.32%

A concise primer on how single-molecule nanopore sequencing is transforming laboratory workflows, enabling long-read insights and expanding translational opportunities at pace

The introduction frames nanopore single-molecule sequencing as a catalytic technology reshaping molecular analysis across research and clinical workflows. Nanopore approaches enable real-time, long-read sequencing of native nucleic acids without amplification, delivering unique capabilities for structural variation detection, epigenetic profiling, direct RNA sequencing, and rapid pathogen identification. Advances in pore chemistry, sensor electronics, and algorithmic basecalling have collectively improved accuracy, throughput, and usability, encouraging broader adoption beyond specialist genomics laboratories.

In parallel, instrument miniaturization and cloud-enabled analytics are lowering barriers to entry for distributed testing and field-deployable applications. This shift supports new use cases in clinical diagnostics, public health surveillance, environmental monitoring, and point-of-care investigation. As a result, stakeholders ranging from academic research centers to commercial biopharma and clinical laboratories are re-evaluating their sequencing infrastructure strategies to incorporate nanopore platforms where long reads, rapid turnaround, and direct modification detection confer distinct advantages.

Looking ahead, the interplay of instrument innovation, consumable economics, and software maturity will determine how rapidly and broadly nanopore sequencing transitions from a specialized capability into a mainstream tool. Strategic investments in interoperability, quality assurance, and regulatory validation will accelerate clinical translation, while collaborative ecosystems of instrument providers, consumable manufacturers, and informatics developers will define the shape of commercial opportunity.

Key technological, operational, and commercial inflection points driving rapid evolution and strategic realignment within the nanopore sequencing ecosystem

The landscape for nanopore sequencing is experiencing multiple transformative shifts that are simultaneously technological, operational, and commercial. Technologically, improvements in pore chemistry, motor proteins, and signal processing have narrowed the accuracy gap with other sequencing modalities while unlocking unique capabilities for direct methylation and RNA modification analysis. These advancements are complemented by algorithmic progress in basecalling and error correction, which together reduce the informatics burden and make long-read outputs more actionable for downstream interpretation.

Operationally, instrument form factors have diversified, ranging from portable devices suitable for fieldwork to higher-throughput platforms designed for centralized laboratories. This diversification is reshaping procurement strategies and enabling hybrid deployment models where point-of-need sequencing feeds into centralized analysis pipelines. Commercially, new business models are emerging that combine instrument sales with recurring consumable revenue and cloud-based software subscriptions, driving predictable revenue streams and tighter customer lock-in. Regulatory progress is also significant; as validation studies and reference standards accumulate, clinical adoption pathways become clearer, accelerating the translation of nanopore assays into diagnostic workflows.

Consequently, ecosystem dynamics are shifting to favor integrative partnerships across hardware, reagents, and software, with a growing premium placed on interoperability, quality control, and end-to-end service delivery. These shifts are creating strategic inflection points for incumbents and new entrants alike, prompting reevaluation of product roadmaps, go-to-market strategies, and partnerships that can scale innovation responsibly and commercially.

How recent US tariff policy shifts drove short-term procurement pressures and long-term supply chain resilience measures across the nanopore sequencing value chain

The cumulative impact of United States tariff adjustments in 2025 created a complex set of headwinds and strategic responses across the nanopore sequencing value chain. Tariff-related cost increases for imported components and instruments raised procurement costs for laboratory operators and service providers, prompting near-term pressure on purchasing cycles and capital expenditure approvals. In response, some manufacturers accelerated localization of supply chains and strategic sourcing to mitigate exposure, while others absorbed costs temporarily to preserve customer relationships in key accounts.

Beyond direct price effects, tariffs influenced partner negotiations and contracting practices. Service organizations and distributors revisited margin structures and contractual clauses to account for potential future policy volatility, and procurement teams incorporated tariff contingencies into purchase planning. These adjustments also contributed to a renewed focus on operational resilience, including dual-sourcing strategies, inventory optimization, and increased scrutiny of upstream suppliers' geographic exposure.

Importantly, the tariff effects catalyzed strategic investment in domestic manufacturing capacity and expanded collaboration with regional suppliers. While such transitions require lead time and capital, they reduce long-term policy risk and can shorten supply chains, improving responsiveness to demand fluctuations. Ultimately, the tariff environment emphasized the importance of agility and scenario planning for organizations operating in the nanopore sequencing market, reinforcing the need to balance cost management with continuity of supply and service quality.

Actionable segmentation intelligence linking product tiers, application domains, end-user demands, and commercial business models to prioritize strategic investments

Segmentation analysis illuminates areas of technological focus, clinical applicability, and commercial targeting that inform strategic planning and product prioritization. Based on Product Type, market is studied across Consumable, Instrument, and Software. The Consumable is further studied across Flow Cells and Kits. The Instrument is further studied across Gridion, Minion, and Promethion. The Software is further studied across Analysis Software and Cloud Solutions. This product-level breakdown underscores that recurring consumables and analytical software are central to commercial models, while instrument tiers address diverse throughput and deployment needs.

Based on Application, market is studied across Clinical Diagnostics, Epigenomics, Genomics, Metagenomics, and Transcriptomics. The breadth of applications highlights how nanopore sequencing serves both discovery-driven research and translational use cases, with particular strengths in structural variant detection, long-range phasing, direct RNA analysis, and methylation mapping. Based on End User, market is studied across Academic Government, Biopharma Pharma, Clinical Laboratories, and Contract Research Organizations. These user segments exhibit distinct procurement cycles, validation demands, and service expectations, requiring tailored engagement strategies and product configurations.

Based on Business Model, market is studied across Product Sales and Service Contracts. Business model choices shape revenue predictability and customer relationships; product sales enable rapid scale, while service contracts and consumable subscriptions create ongoing touchpoints and increase lifetime value. Integrating product, application, end-user, and business model segmentation offers a coherent lens for prioritizing investments, designing pricing, and structuring partnerships.

Regional adoption patterns and regulatory dynamics that shape differentiated strategies for commercial expansion across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics reveal differentiated adoption patterns, regulatory trajectories, and commercialization pathways that influence strategic market entry and expansion decisions. In the Americas, strong academic networks, robust venture funding, and established biotech clusters accelerate technology adoption, especially for translational research and clinical assay development. North American clinical laboratories and biopharma organizations often act as early adopters due to their capacity for validation and scale-up, while field-deployable applications benefit from established public health and defense procurement channels.

In Europe, Middle East & Africa, diverse regulatory regimes and varying infrastructure maturity drive a heterogeneous adoption landscape. Western European markets show strong interest in clinical validation and integrated care pathways, while emerging markets within the region are beginning to leverage nanopore platforms for public health surveillance and agricultural genomics. Regional collaboration frameworks and cross-border research consortia often shape procurement and implementation strategies.

In Asia-Pacific, high-volume diagnostic demand, large-scale sequencing initiatives, and significant manufacturing capabilities create unique opportunities. Rapid digitalization and investments in local production capacity are accelerating adoption, while national genomics programs and public health priorities provide demand signals for both portable and high-throughput solutions. Across regions, localized partnerships, compliance strategies, and support infrastructures remain decisive factors in commercial success.

Competitive and partnership dynamics that reward integrative solutions, validated workflows, and customer-centric services within the nanopore sequencing ecosystem

Competitive dynamics in the nanopore sequencing ecosystem reflect a mixture of incumbent leadership, rapid innovation, and an expanding universe of specialist partners. Leading instrument providers have prioritized iterative hardware improvements, development of consumable ecosystems, and investment in analytics to enhance usability and clinical readiness. At the same time, specialized reagent companies and start-ups are focusing on optimized chemistries and kits that improve throughput, accuracy, and sample preparation workflows. Software vendors and cloud analytics providers are building modular, scalable platforms that support basecalling, variant calling, methylation detection, and integrated visualization, thereby reducing time-to-insight for end users.

Partnerships between instrument manufacturers and informatics companies are increasingly common, enabling bundled solutions that address laboratory validation and regulatory documentation needs. Contract research organizations and clinical laboratories are forming preferred supplier relationships with platform vendors to streamline assay development and diagnostic validation. Additionally, new entrants focused on niche applications-such as environmental metagenomics, rapid infectious disease testing, or agricultural genomics-are carving sustainable positions by aligning product features with specific workflow requirements.

The competitive landscape rewards organizations that couple technical excellence with strong customer support, validated workflows, and an ecosystem of compatible consumables and software. Strategic alliances, co-development agreements, and service offerings that lower the barrier to adoption will remain critical differentiators in a market driven by both technological progress and practical implementation demands.

Practical strategic priorities for executives to accelerate adoption, strengthen resilience, and capture recurring value in the nanopore sequencing market

Industry leaders should pursue a set of pragmatic, high-impact actions to capitalize on emerging opportunities while managing operational risk. First, prioritize modular product roadmaps that align instrument tiers with clear application pathways and validated workflows, enabling customers to match platform capabilities to their use cases. Second, expand consumable ecosystems and subscription-based software offerings to establish recurring revenue and deeper customer engagement, while ensuring transparent pricing and predictable supply commitments.

Third, invest in local and regional supply chain diversification to mitigate geopolitical and tariff-related risks; dual-sourcing of critical components and strategic manufacturing partnerships will reduce vulnerability to policy shifts. Fourth, accelerate clinical validation efforts and generate peer-reviewed evidence to support regulatory submissions and payer discussions, thereby smoothing the path to diagnostic adoption. Fifth, develop comprehensive service and training programs that shorten time-to-value for customers, including curated onboarding, remote support, and turnkey assay development services.

Finally, forge targeted alliances with academic centers, biopharma innovators, and public health agencies to co-develop use cases and demonstrate impact at scale. By combining technical advancement with operational excellence and ecosystem-building, leaders can translate innovation into sustainable commercial growth and meaningful clinical or public health outcomes.

A transparent, multi-method research approach combining primary interviews, technical literature synthesis, and triangulated analysis to support confident strategic decisions

The research methodology integrates qualitative and quantitative approaches designed to yield robust, reproducible insights while minimizing bias and ensuring transparency. Primary research included structured interviews with instrument engineers, laboratory directors, procurement leads, regulatory experts, and senior R&D executives to capture firsthand perspectives on technology performance, validation challenges, and purchasing behavior. These interviews were supplemented by technical reviews of peer-reviewed literature, validation studies, and conference proceedings to ground findings in validated science.

Secondary research canvassed public company filings, patent disclosures, regulatory filings, and technical white papers to map innovation trajectories and supplier strategies. Data triangulation techniques were used to reconcile insights from interviews, literature, and corporate documentation, ensuring that conclusions reflect convergent evidence rather than isolated viewpoints. Analytical methods included qualitative coding of interview data, comparative feature mapping across instruments and consumables, and scenario analysis to assess the impact of supply chain and policy variables.

Throughout the research process, quality controls included cross-checking statements with independent experts, maintaining an audit trail for data sources, and transparently documenting assumptions and limitations. This methodological rigor supports confidence in the strategic recommendations and ensures that the research can be applied directly to product planning, commercial strategy, and operational decision-making.

A strategic wrap-up highlighting technological strengths, operational imperatives, and ecosystem levers required to mainstream nanopore sequencing effectively

In conclusion, nanopore single-molecule sequencing occupies a distinct and expanding niche within the broader genomics landscape, characterized by unique capabilities in long-read analysis, direct modification detection, and real-time data generation. Technological maturation, diversified instrument portfolios, and an evolving software ecosystem are lowering barriers to broader adoption across research, clinical, and field-deployable applications. However, successful scaling will depend on ecosystem-level coordination: robust consumable supply chains, validated workflows, regulatory readiness, and compelling commercial models that deliver predictable value to end users.

Operational resilience-especially in the face of tariff volatility and supply chain disruptions-remains a strategic imperative, as does investment in evidence generation to support clinical translation. Organizations that combine product innovation with strong service offerings, interoperable analytics, and targeted partnerships are best positioned to capture emerging opportunities. By pursuing pragmatic steps to align technology capabilities with customer workflows and regional dynamics, stakeholders can accelerate the transition of nanopore sequencing from a specialized research tool to a mainstream component of translational science and diagnostic practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nanopore Single Molecule Sequencer Market, by Product Type

  • 8.1. Consumable
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
  • 8.2. Instrument
    • 8.2.1. Gridion
    • 8.2.2. Minion
    • 8.2.3. Promethion
  • 8.3. Software
    • 8.3.1. Analysis Software
    • 8.3.2. Cloud Solutions

9. Nanopore Single Molecule Sequencer Market, by Business Model

  • 9.1. Product Sales
  • 9.2. Service Contracts

10. Nanopore Single Molecule Sequencer Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Epigenomics
  • 10.3. Genomics
  • 10.4. Metagenomics
  • 10.5. Transcriptomics

11. Nanopore Single Molecule Sequencer Market, by End User

  • 11.1. Academic Government
  • 11.2. Biopharma Pharma
  • 11.3. Clinical Laboratories
  • 11.4. Contract Research Organizations

12. Nanopore Single Molecule Sequencer Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Nanopore Single Molecule Sequencer Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Nanopore Single Molecule Sequencer Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Nanopore Single Molecule Sequencer Market

16. China Nanopore Single Molecule Sequencer Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 10x Genomics, Inc.
  • 17.6. Agilent Technologies, Inc.
  • 17.7. BGI Genomics Co., Ltd.
  • 17.8. Bio-Rad Laboratories, Inc.
  • 17.9. Direct Genomics Co., Ltd.
  • 17.10. Eurofins Scientific SE
  • 17.11. F. Hoffmann-La Roche Ltd
  • 17.12. Genapsys, Inc.
  • 17.13. Hitachi High-Technologies Corporation
  • 17.14. Illumina, Inc.
  • 17.15. Microsynth AG
  • 17.16. Nabsys, Inc.
  • 17.17. Oxford Nanopore Technologies plc
  • 17.18. Pacific Biosciences of California, Inc.
  • 17.19. PerkinElmer, Inc.
  • 17.20. QIAGEN N.V.
  • 17.21. Quantum Biosystems Inc.
  • 17.22. SeqLL Inc.
  • 17.23. Stratos Genomics, Inc.
  • 17.24. Thermo Fisher Scientific Inc.
  • 17.25. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 150. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 152. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 184. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)